Preparing independent, creative leaders in the pharmaceutical sciences and in the application of genetics and genomics to the development of safe, effective drugs for patients
A new video produced by the American Museum of Natural History features the work of Esteban Burchard, MD, MPH, and members of his laboratory.
“Genes and Health: Moving Beyond Race,” shows how Burchard’s lab is using differences in the ancestry of asthma patients to help find genetic variations...
Magnetic resonance imaging (MRI), used with a novel pyruvate chemical compound that is specially labeled to be read by the MRI machine, is being applied for the first time in humans to study the aggressiveness of prostate cancer in patients and the success of prostate cancer therapies.
The implantable bioartificial kidney is explained in this December 6, 2010, SmartPlanet video featuring Shuvo Roy, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine.
Shuvo Roy, PhD, an engineer and research scientist, is leading a U.S. project to build the world’s first bioartificial kidney to treat end stage renal disease. The goal is to surgically implant this coffee-cup-sized device in a human patient within 5 to 7 years.
A national research project is under way to develop an surgically implantable bioartificial kidney using the latest advances in science and technology with the goal of both improving the health and lives of patients with end stage renal disease and saving health care dollars.
The model for a surgically implantable bioartificial kidney the size of a coffee cup has been unveiled by the national project's lead researcher, Shuvo Roy, PhD, a member of the UCSF Department of Bioengineering and Therapeutic Sciences.
Synthetic biologist and UCSF School of Pharmacy faculty member Christopher Voigt, PhD, and Jeffrey Tabor, a postdoctoral scholar in Voigt's laboratory, discuss the field and promise of synthetic biology in this July 21, 2009 KQED television segment.